ADMA Biologics Inc (ADMA)
20.20
-1.27
(-5.92%)
USD |
NASDAQ |
Nov 14, 16:00
20.13
-0.07
(-0.35%)
After-Hours: 06:57
ADMA Biologics Free Cash Flow (Quarterly): 23.93M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 23.93M |
| June 30, 2024 | 43.28M |
| March 31, 2024 | -4.58M |
| December 31, 2023 | 16.19M |
| September 30, 2023 | 11.23M |
| June 30, 2023 | -6.931M |
| March 31, 2023 | -16.67M |
| December 31, 2022 | -11.13M |
| September 30, 2022 | -16.67M |
| June 30, 2022 | -16.77M |
| March 31, 2022 | -28.86M |
| December 31, 2021 | -37.14M |
| September 30, 2021 | -16.20M |
| June 30, 2021 | -36.74M |
| March 31, 2021 | -35.80M |
| December 31, 2020 | -35.82M |
| September 30, 2020 | -26.74M |
| June 30, 2020 | -25.45M |
| March 31, 2020 | -26.72M |
| December 31, 2019 | -21.25M |
| September 30, 2019 | -25.60M |
| June 30, 2019 | -18.76M |
| March 31, 2019 | -14.40M |
| December 31, 2018 | -19.61M |
| September 30, 2018 | -12.77M |
| Date | Value |
|---|---|
| June 30, 2018 | -15.41M |
| March 31, 2018 | -16.98M |
| December 31, 2017 | -15.37M |
| September 30, 2017 | -10.31M |
| June 30, 2017 | -8.868M |
| March 31, 2017 | -5.402M |
| December 31, 2016 | -3.624M |
| September 30, 2016 | -4.688M |
| June 30, 2016 | -4.845M |
| March 31, 2016 | -5.185M |
| December 31, 2015 | -4.074M |
| September 30, 2015 | -2.682M |
| June 30, 2015 | -4.454M |
| March 31, 2015 | -4.235M |
| December 31, 2014 | -3.459M |
| September 30, 2014 | -3.862M |
| June 30, 2014 | -4.555M |
| March 31, 2014 | -5.152M |
| December 31, 2013 | -2.965M |
| September 30, 2013 | -2.242M |
| June 30, 2013 | -2.736M |
| March 31, 2013 | -3.141M |
| December 31, 2012 | -1.842M |
| September 30, 2012 | -2.129M |
| June 30, 2012 | -1.053M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-37.14M
Minimum
Dec 2021
43.28M
Maximum
Jun 2024
-13.44M
Average
-16.72M
Median
Free Cash Flow (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 72.19M |
| Madrigal Pharmaceuticals Inc | -67.76M |
| Assembly Biosciences Inc | -17.12M |
| TG Therapeutics Inc | -12.23M |
| Krystal Biotech Inc | 57.81M |